WeVote
Log In

Bill

Bill

A 3107

Provides for the creation of a drug guide for seniors regarding the drugs commonly used by people over 62 years of age

2025 Regular Session Introduced by Alicia Hyndman

Creates a drug guide for seniors 62+ on commonly used meds to boost literacy and safety, helping patients, caregivers, and providers prevent adverse drug events.

REFERRED TO AGING
0
WeVote Research Nonpartisan
Bill Summary · A 3107

Summary of Bill A 3107

Bill at a glance

  • Bill Number: A 3107
  • Title/Purpose: Provides for the creation of a drug guide for seniors regarding the drugs commonly used by people over 62 years of age.
  • Status: Referred to the Aging Committee.
  • Introduced: January 23, 2025
  • Sponsor: Alicia Hyndman (primary)

What the bill would do

  • The bill aims to establish the creation of a drug guide specifically for seniors, focusing on medications commonly used by people aged 62 and older.
  • As of the information available, the full text with detailed provisions has not been provided. The summary indicates a focus on guiding seniors in understanding and managing medications they or their caregivers may encounter.

Key provisions (as described)

  • The provided information does not include the specific statutory language or subsections.
  • It is stated that the bill would create a drug guide for seniors; further details (who would develop, how the guide would be distributed, content standards, funding, oversight, updates, and accessibility requirements) are not listed in the available materials.

Who would be affected

  • Primary audience: Seniors aged 62 and older who use prescription or over-the-counter medications.
  • Secondary audiences: Caregivers, family members, healthcare providers (e.g., physicians, pharmacists), and state aging agencies that would potentially participate in development, dissemination, or promotion of the guide.

Legislative status and process

  • Current stage: Referred to the Aging Committee, indicating formal review and potential committee hearings.
  • Action history: Both entries listed for January 23, 2025 show the bill being referred to Aging.
  • In typical legislative practice, after committee consideration, the bill could be amended, approved by the committee, and then advanced to the floor for consideration.

Sponsorship and related bills

  • Primary sponsor: Alicia Hyndman.
  • Related/companion bills (prior-session):
    • S 7739, S 3585, S 3291, S 3678, A 5033 (prior-session)
    • S 2448 (companion)
      These related bills suggest ongoing interest in senior medication information and safety across sessions.

Potential impact and considerations

  • If enacted, the bill could improve medication literacy and safety for older adults, potentially reducing adverse drug events and interactions through better access to information.
  • Implementation considerations (not specified in the available text) would likely include funding, partnerships with aging or health agencies, formats accessible to diverse populations, and regular updates to reflect new medications and guidelines.
  • Monitoring and evaluation would be important to assess effectiveness and reach.

Next steps for readers

  • Watch for committee hearings in the Aging Committee for bill amendments, testimony, and votes.
  • Review the full text when available to understand specific responsibilities, timelines, funding, and implementation details.

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.